Pharmacoeconomics-Open

Scope & Guideline

Fostering Innovation in Health Economics

Introduction

Welcome to the Pharmacoeconomics-Open information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Pharmacoeconomics-Open, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2509-4262
PublisherSPRINGER INT PUBL AG
Support Open AccessYes
CountrySwitzerland
TypeJournal
Convergefrom 2017 to 2024
AbbreviationPHARMACOECON-OPEN / Pharmacoecon.-Open
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGEWERBESTRASSE 11, CHAM CH-6330, SWITZERLAND

Aims and Scopes

Pharmacoeconomics-Open is dedicated to advancing the field of pharmacoeconomics and health economics through rigorous analysis and evaluation of healthcare interventions. The journal emphasizes the importance of economic evaluations in informing healthcare decision-making and policy formulation.
  1. Cost-Effectiveness Analysis (CEA):
    The journal publishes extensive research on cost-effectiveness analyses of various healthcare interventions, including pharmaceuticals, medical devices, and treatment protocols, providing a comprehensive understanding of their economic value.
  2. Health Technology Assessment (HTA):
    Pharmacoeconomics-Open focuses on health technology assessments that evaluate the clinical efficacy, safety, and economic implications of new treatments and technologies, guiding stakeholders in healthcare decision-making.
  3. Budget Impact Analysis (BIA):
    The journal includes studies on budget impact analyses, evaluating the financial implications of adopting new therapies or technologies within specific healthcare systems, aiding in resource allocation and policy planning.
  4. Patient-Centered Outcomes:
    Research highlighting patient-reported outcomes and quality of life assessments is central to the journal's scope, emphasizing the importance of patient perspectives in evaluating healthcare interventions.
  5. Methodological Innovations in Economic Evaluation:
    Pharmacoeconomics-Open encourages submissions that explore new methodologies in economic evaluation, including modeling techniques and statistical approaches, to enhance the rigor and applicability of pharmacoeconomic studies.
Pharmacoeconomics-Open is witnessing emerging themes that reflect the evolving landscape of healthcare economics and the increasing complexity of healthcare interventions. These trends highlight the journal's responsiveness to contemporary challenges and innovations in the field.
  1. Integration of Artificial Intelligence (AI):
    Recent publications emphasize the role of AI in automating health economic modeling and decision-making processes, showcasing innovative applications that enhance efficiency and accuracy in economic evaluations.
  2. Real-World Evidence (RWE):
    There is a growing trend towards incorporating real-world evidence in economic evaluations, with studies focusing on the effectiveness and cost implications of interventions in routine clinical practice, rather than controlled trial settings.
  3. Value-Based Healthcare Models:
    Emerging research emphasizes value-based healthcare approaches that assess treatments based on their outcomes relative to costs, reflecting a shift in focus from volume-based care to value-driven systems.
  4. Patient-Centered and Multi-Criteria Decision Analysis:
    An increasing number of studies are employing multi-criteria decision analysis (MCDA) frameworks that incorporate diverse stakeholder preferences, including patient values, in the evaluation of healthcare interventions.
  5. Global Health Economics:
    The journal is seeing a rise in submissions addressing global health economics, particularly in low- and middle-income countries, highlighting unique challenges and opportunities in these contexts.

Declining or Waning

While Pharmacoeconomics-Open continues to thrive in many areas, certain themes appear to be waning in prominence over the recent years. This decline may reflect shifts in research focus or changing priorities in healthcare economics.
  1. Traditional Cost-Utility Analysis:
    There is a noticeable decline in the frequency of traditional cost-utility analyses focusing solely on generic health states, as researchers increasingly adopt more nuanced approaches that incorporate broader patient-reported outcomes.
  2. Single-Condition Focused Studies:
    Research solely centered on specific diseases or conditions, such as individual cancers or chronic illnesses, is becoming less prevalent, with a shift towards studies that consider broader healthcare systems and multiple conditions.
  3. Static Economic Models:
    The use of static economic models that do not account for real-world variability and long-term outcomes is decreasing, as there is a growing preference for dynamic modeling approaches that reflect changing patient populations and treatment landscapes.

Similar Journals

HEALTH ECONOMICS

Pioneering research that shapes global health economics.
Publisher: WILEYISSN: 1057-9230Frequency: 12 issues/year

HEALTH ECONOMICS is a premier academic journal published by Wiley, dedicated to advancing the field of health economics. With an ISSN of 1057-9230, this journal has been a vital resource since its inception in 1992, and continues to contribute significantly to the academic landscape as it extends its cover to 2024. With a distinguished ranking of Q1 in Health Policy for 2023, it showcases cutting-edge research and theoretical advancements that inform health policy and economic decision-making globally. The journal features rigorous peer-reviewed articles that address a diverse range of topics within health economics, making it an essential platform for researchers, financial analysts, policymakers, and students alike. Although not an Open Access journal, it strives to ensure accessibility of critical insights for a broad audience, further enhancing its influence within the health economics community.

American Economic Journal-Economic Policy

Shaping the Future of Economic Governance
Publisher: AMER ECONOMIC ASSOCISSN: 1945-7731Frequency: 4 issues/year

American Economic Journal - Economic Policy, published by the American Economic Association, stands at the forefront of economic research, focusing on significant policy implications and evidence-based evaluations. With an ISSN of 1945-7731 and an E-ISSN of 1945-774X, this esteemed journal has maintained its influence and credibility in the field since its inception in 2009. Ranked in the Q1 category for Economics, Econometrics and Finance and ranking #7 out of 288 in Scopus, it boasts a remarkable 97th percentile ranking, making it a premier source for cutting-edge research and policy discussion. The journal's rigorous peer-reviewed articles aim to bridge the gap between academic research and real-world economic policy, serving as an essential resource for researchers, professionals, and students who seek to engage with and contribute to the evolving landscape of economic policy. With open access options not currently available, readers are encouraged to subscribe or access articles through academic institutions for comprehensive insights into the economic challenges and innovations shaping our world.

MEDICAL DECISION MAKING

Shaping the future of healthcare through evidence-based research.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Expert Review of Pharmacoeconomics & Outcomes Research

Elevating Standards in Pharmacoeconomic Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7167Frequency: 6 issues/year

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

ADVANCES IN THERAPY

Elevating medical research to new heights.
Publisher: SPRINGERISSN: 0741-238XFrequency: 12 issues/year

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

Health Economics Review

Driving change in health systems through collaborative research.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.

VALUE IN HEALTH

Fostering Global Health Improvement Through Rigorous Scholarship
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

JOURNAL OF HEALTH ECONOMICS

Connecting Research and Policy for Enhanced Health Outcomes
Publisher: ELSEVIERISSN: 0167-6296Frequency: 6 issues/year

JOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.

Health Services Management Research

Exploring Innovations in Health Services Research
Publisher: SAGE PUBLICATIONS LTDISSN: 0951-4848Frequency: 4 issues/year

Health Services Management Research is a premier academic journal published by SAGE PUBLICATIONS LTD, focusing on critical areas within the health policy domain. With an ISSN of 0951-4848 and E-ISSN 1758-1044, this UK-based journal has been a valuable resource for over three decades, converging from 1988 to 2024. Recognized for its contribution to the field, it holds a commendable Q2 quartile ranking, positioning it in the top 35% of journals in Health Policy, reflecting its significant impact within the academic community, as evidenced by its rank of 109 out of 310 in Scopus rankings, placing it in the 65th percentile. The journal aims to foster innovative research that addresses the complexities of health services management, making it an indispensable resource for researchers, professionals, and students dedicated to improving health systems. Although it currently does not offer Open Access, the journal remains committed to advancing knowledge and practice in health policy management through rigorous peer-reviewed articles, case studies, and evidence-based analyses.

Health Policy OPEN

Transforming health policy insights into actionable solutions.
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

Health Policy OPEN is an esteemed open-access journal published by Elsevier that has made significant contributions to the field of health policy since its inception in 2020. With an impact factor placing it in the prestigious Q2 category of health policy journals, it ranks 116 out of 310 within the Scopus database, highlighting its critical engagement in the field and situating it within the 62nd percentile. As an open-access platform, Health Policy OPEN promotes the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students alike. The journal focuses on topical issues, innovative approaches, and evidence-based practices that shape health policies worldwide. With its headquarters in Amsterdam, Netherlands, the journal serves as a vital resource for advancing knowledge and fostering discussions that drive health policy initiatives and reforms. Engage with Health Policy OPEN to contribute to the evolving landscape of health policy and to stay informed on the latest research advancements.